2006
DOI: 10.1515/cclm.2006.111
|View full text |Cite
|
Sign up to set email alerts
|

Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients

Abstract: Changes in erythrocyte ADE activities suggest that oxidative stress, involved in the motor neurone pathogenesis of SALS and FALS, also has systemic effects. Differences in ADE systems between the study groups revealed the presence of different types of oxidative pressure, indicating the potential additional benefit of individually designed anti-oxidant cocktail therapies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
32
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 47 publications
(34 citation statements)
references
References 31 publications
2
32
0
Order By: Relevance
“…In fact, a recent series of studies suggest the possibility of systemic involvement in sALS [27]. In ALS patients, cultured monocytes have increased inflammatory cytokine production [28], cutaneous collagen fibers are abnormal [29], systemic glutamate metabolism is impaired [30], the antioxidative defense system of erythrocytes is reduced [31], patients are in a hypermetabolic state due to abnormal skeletal muscle metabolism [32], and muscle mitochondria are not only structurally abnormal [33,34], but have primary abnormalities known to cause an ALS-like syndrome [35]. A major source of 'systemic' oxidative stress is clearly generated in skeletal muscle, which constitutes 40 to 45% of body mass [36].…”
Section: Discussionmentioning
confidence: 99%
“…In fact, a recent series of studies suggest the possibility of systemic involvement in sALS [27]. In ALS patients, cultured monocytes have increased inflammatory cytokine production [28], cutaneous collagen fibers are abnormal [29], systemic glutamate metabolism is impaired [30], the antioxidative defense system of erythrocytes is reduced [31], patients are in a hypermetabolic state due to abnormal skeletal muscle metabolism [32], and muscle mitochondria are not only structurally abnormal [33,34], but have primary abnormalities known to cause an ALS-like syndrome [35]. A major source of 'systemic' oxidative stress is clearly generated in skeletal muscle, which constitutes 40 to 45% of body mass [36].…”
Section: Discussionmentioning
confidence: 99%
“…The ADS in human erythrocytes with preserved homeostasis finely retunes its composition according to plasma oxidative demands. An increase in the level of a specific plasma lipid component may potentiate mem brane lipid peroxidation in erythrocytes and decrease intraerythrocyte production of O 2 .-, which could result in a negative correlation between SOD and GSH-Px activities found in some experiments (6)(7)(8)(9). The discovery of the haemoglobin-cholesterol (Hb-Ch) complex implies the way in which cholesterol may influence the organisation of ADS in erythrocytes (7).…”
Section: Introductionmentioning
confidence: 99%
“…Non-specific inter actions of ROS with different classes of intracellular molecules induce oxidative damage leading to the impairment of cellular homeostasis. As accurate detection of in vivo ROS concentrations is still problematic, changes in the ADS may serve as a good indicator of processes within the organism, as it responds to ROS production, changes of the environment (as low environmental temperature) (11) and pathological conditions (9). It should be stressed that the ADS is species-and tissue-specific (12) and that antioxidative enzymes in erythrocytes and the do minant source of ROS in erythrocytes are in many aspects quite different in comparison with extracellular fluids and other tissues.…”
Section: Introductionmentioning
confidence: 99%
“…Evidence for oxidative damage to proteins and lipids has been detected in serum, fibroblasts, and the central nervous system (CNS) of ALS patients as well as various organs in the G93A mutant SOD1 transgenic murine model of ALS (13)(14)(15)(16)(17)(18)(19)(20). A central regulator of cellular responses to oxidative stress is the NRF2 (NF-E2-related factor 2)/KEAP1 (Kelch-like ECH-associated protein 1) pathway.…”
mentioning
confidence: 99%